Antibodies against the cancer-testis antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical-recurrence
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference23 articles.
1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006
2. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results;Roehl;J Urol,2004
3. Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer;Grossfeld;J Urol,2003
4. Prognostic factors in prostate cancer;Buhmeida;Diagn Pathol,2006
5. Molecular markers of prostate cancer outcome;Quinn;Eur J Cancer,2005
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Humoral immune responses against cancer-testis antigens in human malignancies;Human Antibodies;2019-11-15
2. Genetic and molecular determinants of prostate cancer among Iranian patients: An update;Critical Reviews in Clinical Laboratory Sciences;2019-09-06
3. Cancer/Testis Antigens Differentially Expressed in Prostate Cancer: Potential New Biomarkers and Targets for Immunotherapies;2019-05-23
4. Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapy;Immunotherapy;2017-09
5. Immunology of chronic myeloid leukemia: current concepts and future goals;Expert Review of Clinical Immunology;2015-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3